I. Ertenli Et Al. , "The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry," ARTHRITIS & RHEUMATOLOGY , vol.67, 2015
Ertenli, I. Et Al. 2015. The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry. ARTHRITIS & RHEUMATOLOGY , vol.67 .
Ertenli, I., KARADAĞ, Ö., PEHLİVAN, Y., Dalkilic, E., Onat, A. M., Kisacik, B., ... CAN, G.(2015). The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry. ARTHRITIS & RHEUMATOLOGY , vol.67.
Ertenli, Ihsan Et Al. "The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry," ARTHRITIS & RHEUMATOLOGY , vol.67, 2015
Ertenli, Ihsan Et Al. "The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry." ARTHRITIS & RHEUMATOLOGY , vol.67, 2015
Ertenli, I. Et Al. (2015) . "The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry." ARTHRITIS & RHEUMATOLOGY , vol.67.
@article{article, author={Ihsan Ertenli Et Al. }, title={The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2015}